Ship in Europe, Find out rates!
Language
Connettivinagel Healing 0.2% Hyaluronic Acid 30g
Regular Price
€17.30
Special Price
€12.94
-25%
Save: €4.36
In stock
Recent lowest price:
€13.05
- box Delivery in Italy in 24/48 and free returns
- star3.000+ positive reviews
- dropboxOver 60,000 products in the catalog
NAME
CONNECTIVINE
PHARMACOTHERAPEUTIC CATEGORY
Preparations for the treatment of wounds and ulcerations.
ACTIVE PRINCIPLES
Hyaluronic acid sodium salt.
EXCIPIENTS
Cream 2 mg / g: polyethylene glycol 400 monostearate; decyl ester of oleic acid; emulsifying wax; glycerol; 70% sorbitol solution; methyl p-hydroxybenzoate; propyl p-hydroxybenzoate; aroma (Dalin PH); purified water. Gel 2 mg / g: 70% sorbitol not crystallizable; methyl p-hydroxybenzoate; propyl p-hydroxybenzoate; carbomer 940; sodium hydroxide; purified water.
INDICATIONS
Treatment of abrasions, grazes, superficial wounds, burns, minor burns and breast fissures; treatment of localized skin irritations caused by physical agents such as sun, cold, wind, diaper redness, irritation and dehydration resulting from radiotherapy treatments.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance and other closely related substances from a chemical point of view or to any of the excipients listed.
DOSAGE
Cream 2 mg / g, Gel 2 mg / g: 2-3 applications per day, evenly covering the entire affected area.
STORAGE
Cream: do not store above 30 degrees C. Gel: do not store above 25 degrees C.
WARNINGS
The use of the product, especially if prolonged, can give rise to sensitization phenomena. If this happens it is necessary to interrupt the treatment and institute a suitable therapy.
INTERACTIONS
The association of hyaluronic acid with antibiotics and other local treatments has never given rise to interaction phenomena. Do not use simultaneously with disinfectants containing quaternary ammonium salts as hyaluronic acid can precipitate in their presence.
SIDE EFFECTS
Following application of the drug, local reactions, including allergic ones, were recorded. The reporting of suspected adverse reactions that occur after the authorization of the drug is important, as it allows continuous monitoring of the benefit / risk ratio of the drug.
PREGNANCY AND BREASTFEEDING
The drug can 'be used during pregnancy and lactation.
CONNECTIVINE
PHARMACOTHERAPEUTIC CATEGORY
Preparations for the treatment of wounds and ulcerations.
ACTIVE PRINCIPLES
Hyaluronic acid sodium salt.
EXCIPIENTS
Cream 2 mg / g: polyethylene glycol 400 monostearate; decyl ester of oleic acid; emulsifying wax; glycerol; 70% sorbitol solution; methyl p-hydroxybenzoate; propyl p-hydroxybenzoate; aroma (Dalin PH); purified water. Gel 2 mg / g: 70% sorbitol not crystallizable; methyl p-hydroxybenzoate; propyl p-hydroxybenzoate; carbomer 940; sodium hydroxide; purified water.
INDICATIONS
Treatment of abrasions, grazes, superficial wounds, burns, minor burns and breast fissures; treatment of localized skin irritations caused by physical agents such as sun, cold, wind, diaper redness, irritation and dehydration resulting from radiotherapy treatments.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance and other closely related substances from a chemical point of view or to any of the excipients listed.
DOSAGE
Cream 2 mg / g, Gel 2 mg / g: 2-3 applications per day, evenly covering the entire affected area.
STORAGE
Cream: do not store above 30 degrees C. Gel: do not store above 25 degrees C.
WARNINGS
The use of the product, especially if prolonged, can give rise to sensitization phenomena. If this happens it is necessary to interrupt the treatment and institute a suitable therapy.
INTERACTIONS
The association of hyaluronic acid with antibiotics and other local treatments has never given rise to interaction phenomena. Do not use simultaneously with disinfectants containing quaternary ammonium salts as hyaluronic acid can precipitate in their presence.
SIDE EFFECTS
Following application of the drug, local reactions, including allergic ones, were recorded. The reporting of suspected adverse reactions that occur after the authorization of the drug is important, as it allows continuous monitoring of the benefit / risk ratio of the drug.
PREGNANCY AND BREASTFEEDING
The drug can 'be used during pregnancy and lactation.
| Destination | Cost | Detail |
|---|---|---|
| Italy | €5,90* | 24/72H |
| Austria, France, Germany, Slovenia | € 13* | 3 days |
| Belgium, Luxembourg, Portugal, Netherlands, Spain | € 14* | 4 days |
| Bulgary, Cechia, Hungary, Poland, Romania, Slovakia | € 19* | 5 days |
| Denmark, Estonia, Finland, Ireland, Lithuania, Latvia ,Sweden | € 22* | 5 days |
| United Kingdom, Switzerland, Greece, Malta/td> | € 30* | 7 days |
| Canada | € 40 | 7 Days |
European shipments with express courier: FedEx, MBE, DHL
*For the shipment outside band B ther's an extra cost of 22€ *For the shipment outside band C ther's an extra cost of 30€ Delivery Times exclude Saturday and Holidays
For Islands and Areas of difficult Accessibility the shipments are made in 72 hours and the cost will be increased by 15€
The images of the products shown on our site are purely indicative and may differ in shape, color, text and packaging shown on them. Given the difficulty of updating all the products on our site in real time or any errors, XFarma.it, all products will be identified through SKU MINSAN (code of the Ministry of Health).